Rohlen Explains How KKR, Ajax Are Rethinking How We Run Medtech Start-ups
Duke Rohlen, CEO and director of Ajax Health, co-founder and CEO of Spirox Inc., explains how he’s combining his expertise, connections, and experience exiting Medtech companies with KKR’s capital to devise a new way to run start-ups.
Rohlen Explains How KKR, Ajax Are Rethinking How We Run Medtech Start-ups
Duke Rohlen, CEO and director of Ajax Health, co-founder and CEO of Spirox Inc., explains how he’s combining his expertise, connections, and experience exiting Medtech companies with KKR’s capital to devise a new way to run start-ups.